Thomson John P, Lempiäinen Harri, Hackett Jamie A, Nestor Colm E, Müller Arne, Bolognani Federico, Oakeley Edward J, Schübeler Dirk, Terranova Rémi, Reinhardt Diana, Moggs Jonathan G, Meehan Richard R
Genome Biol. 2012 Oct 3;13(10):R93. doi: 10.1186/gb-2012-13-10-r93.
Induction and promotion of liver cancer by exposure to non-genotoxic carcinogens coincides with epigenetic perturbations, including specific changes in DNA methylation. Here we investigate the genome-wide dynamics of 5-hydroxymethylcytosine (5hmC) as a likely intermediate of 5-methylcytosine (5mC) demethylation in a DNA methylation reprogramming pathway. We use a rodent model of non-genotoxic carcinogen exposure using the drug phenobarbital.
Exposure to phenobarbital results in dynamic and reciprocal changes to the 5mC/5hmC patterns over the promoter regions of a cohort of genes that are transcriptionally upregulated. This reprogramming of 5mC/5hmC coincides with characteristic changes in the histone marks H3K4me2, H3K27me3 and H3K36me3. Quantitative analysis of phenobarbital-induced genes that are involved in xenobiotic metabolism reveals that both DNA modifications are lost at the transcription start site, while there is a reciprocal relationship between increasing levels of 5hmC and loss of 5mC at regions immediately adjacent to core promoters.
Collectively, these experiments support the hypothesis that 5hmC is a potential intermediate in a demethylation pathway and reveal precise perturbations of the mouse liver DNA methylome and hydroxymethylome upon exposure to a rodent hepatocarcinogen.
接触非基因毒性致癌物诱导和促进肝癌的过程与表观遗传扰动同时发生,包括DNA甲基化的特定变化。在此,我们研究5-羟甲基胞嘧啶(5hmC)在DNA甲基化重编程途径中作为5-甲基胞嘧啶(5mC)去甲基化可能中间体的全基因组动态变化。我们使用苯巴比妥药物建立非基因毒性致癌物暴露的啮齿动物模型。
接触苯巴比妥导致一组转录上调基因启动子区域的5mC/5hmC模式发生动态且相互的变化。5mC/5hmC的这种重编程与组蛋白标记H3K4me2、H3K27me3和H3K36me3的特征性变化一致。对参与异生物质代谢的苯巴比妥诱导基因的定量分析表明,在转录起始位点,两种DNA修饰均消失,而在紧邻核心启动子的区域,5hmC水平升高与5mC丢失之间存在相互关系。
总体而言,这些实验支持5hmC是去甲基化途径中潜在中间体的假说,并揭示了接触啮齿动物肝癌致癌物后小鼠肝脏DNA甲基化组和羟甲基化组的精确扰动。